Proliferative diabetic retinopathy-The influence of diabetes control on the activation of the intraocular molecule system

Diabetes Research and Clinical Practice

Volumn 84, Issue 1, 2009, Pages 46-50

  Adamiec Mroczek, Joanna ^a   Oficjalska Młyńczak, Jolanta ^a   Misiuk Hojło, Marta ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

PDR; VCAM 1; vWF

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; RETINA BLOOD FLOW; RETINA INJURY; VITRECTOMY;

ADULT; AGED; DIABETIC RETINOPATHY; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; RETINA; VASCULAR CELL ADHESION MOLECULE-1; VITREOUS BODY;

EID: 62049084111     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.01.012     Document Type: Article

References (25)

1. Barile G.R., Chang S., Park L., Reppucci V.S., Schiff W.M., and Schmidt A.M. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Curr. Eye Res. 19 3 (1999) 219-227
2. Balasubramanyam M., Rema M., and Premanand C. Biochemical and molecular mechanisms of diabetic retinopathy. Curr. Sci. 83 12 (2002) 1506-1514
3. Hammes H.P., Lin J., Renner O., Shani M., Lundqvist A., Bestholz Ch., et al. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 51 10 (2002) 3107-3112
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
5. Ways D.K., and Sheetz M.J. The role of protein kinase C in the development of the complications of diabetes. Vitam. Horm. 60 (2001) 149-159
6. Hammes H.P. Pathophysiological mechanisms of diabetic angiopathy. J. Diabetes Complications 17 2 (2003) 16-19
7. Bednarska-Chabowska D., Adamiec R., Rychlik-Golema W., and Adamiec J. Selected problems of endothelial functions. II. The role of the selectines in the damage of the vascular endothelium. Pol. Merkur. Lekarski. 12 70 (2002) 322-327
8. Fong D.S., Aiello L., Ferris F.L., and Klein R. Diabetic retinopathy. Diabetes Care 27 (2004) 2540-2553
9. Blüher M., Unger R., Rassoul F., Reppucci V.S., Schiff W.M., and Schmidt A.M. Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or type II diabetes. Diabetologia 45 2 (2002) 210-216
10. Adamis A.P. Is diabetic retinopathy an inflammatory disease?. Br. J. Ophthalmol. 86 (2002) 363-365
11. Barouch F.C., Miyamoto K., Allport J.R., Fujita K., Bursell S.E., Aiello L.P., et al. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest. Ophthalmol. Vis. Sci. 41 5 (2000) 1153-1158
12. Abiko T., Abiko A., and Clermont A.C. Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes. Diabetes 52 (2003) 829-837
13. Bednarska-Chabowska D., Adamiec R., Rychlik-Golema W., and Adamiec J. Selected problems of endothelial functions. II. The role of endothelium in maintaining the hematological and circulatory balance. Pol. Merkur. Lekarski. 2 70 (2002) 322-327
14. Kokura S., Wolf R.E., Yoshikawa T., Ichikawa H., Granger D.N., and Ty A.W. Endothelial cells exposed to anoxia/reoxygenationare hyperadhesive to T-lymphocytes: kinetics and molecular mechanisms. Microcirculation 7 (2000) 13-23
15. Tailor A., and Granger D.N. Role of adhesion molecules in vascular regulation and damage. Curr. Hypertens. Rep. 2 (2000) 78-83
16. Mamputu J.C., and Renier G. Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants. J. Leukoc. Biol. 75 6 (2004) 1062-1069
17. Limb G., Hollifield R., Webster L., Charteris D., and Chignell A. Soluble TNF receptors in vitreoretinal proliferative disease. Invest. Ophthalmol. Vis. Sci. 142 (2001) 1586-1591
18. American Diabetes Association. Clinical practice recommendations. Diabetes Care (2004) 27
19. International Diabetes Federation. Global Guidelines for Type 2 Diabetes (2005), IDF Brussels
20. Schroeder S., Palinski W., and Schmidt-Schonbein G.W. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am. J. Pathol. 139 (1991) 81-100
21. Kessler L., Wiesel M.L., Attali P., Massard J.M., Cazenawe J.P., and Pinget M. Von Willebrand factor in diabetic angiopathy. Diabetes Metab. 24 4 (2000) 327-336
22. Tamura H., Miyamoto K., Kiryu J., Miyahara S., Katsuta H., Hirose F., et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest. Ophthalmol. Vis. Sci. 46 4 (2005) 1440-1444
23. 164 is proinflammatory in the diabetic retina. Invest. Ophthalmol. Vis. Sci. 44 5 (2003) 2155-2162
24. Joussen A.M., Poulaki V., Qin W., Kirchhof B., Mitsiades N., Wiegand S.J., et al. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am. J. Pathol. 160 (2002) 501-509
25. Quam T., Xu Q., Joussen A.M., Clemens M.W., Qin W., Miyamoto K., et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2408-2413